C09999453 / invoice 10000
Species:CANINE
Breed:British Bulldog
Age (years):6
Diagnosis or signs:Medication
Consult notes
Plan for Sully:β’ Continue strict diet trialβ’ Continue sulfasalazine 1 tablet SID β’ Start cyclosporine 5 mg/kg SID- prescription for owner to source from chemist - will taper β’ Resume antibiotic course and add in amoxyclav alongside metronidazole for 3 weeks given previous culture** consider budesonideCyclosporineDuration:4β6 weeks minimumGoal during this phase:resolve clinical signsstabilise rectal inflammationstop recurrent anal sac infectionMany clinicians will not taper before 6 weeks, even if the dog looks better earlier.2. First taper (reduce frequency)Once stable for 2β4 weeks with no relapse:Reduce to 5 mg/kg every 48 hours for 4-6 weeks Monitor for recurrence of:rectal bleedingmucusanal gland dischargescooting or discomfortIf relapse occurs ? return to daily dosing.3. Second taperIf still stable after the EOD phase reduce to 5 mg/kg every 72 hoursContinue for 4β8 weeksSome dogs remain stable here long term.4. Long-term maintenance optionsDepending on the dogβs response, maintenance may be every 72 hours vs twice weekly or occasionally discontinuedMany chronic colitis dogs remain stable on low-frequency cyclosporine.5. Practical example protocolA common timeline:Weeks 0β6? 5 mg/kg SIDWeeks 6β12? 5 mg/kg EODWeeks 12β20? 5 mg/kg every 72 hrThen reassess whether ongoing therapy is needed.6. Drugs often continued alongside cyclosporineSulfasalazine during inductionstrict diet trial (e.g. Hill's Prescription Diet z/d)Sulfasalazine is sometimes tapered after cyclosporine is stabilised.7. Monitoring while on cyclosporineMost clinicians check:Baseline then periodic:CBCbiochemistryurinalysisWatch for:GI upset (most common early effect)gingival hyperplasiapapillomasopportunistic infectionsClinical improvement usually appears within 2β4 weeksFull mucosal stabilisation may take 6β8 weeks
Animal clinical history (3 most recent)
2026-03-05T00:00:00Z 8:19?pm
Plan for Sully:β’ Continue strict diet trialβ’ Continue sulfasalazine 1 tablet SID β’ Start cyclosporine 5 mg/kg SID- prescription for owner to source from chemist - will taper β’ Resume antibiotic course and add in amoxyclav alongside metronidazole for 3 weeks given previous culture** consider budesonideCyclosporineDuration:4β6 weeks minimumGoal during this phase:resolve clinical signsstabilise rectal inflammationstop recurrent anal sac infectionMany clinicians will not taper before 6 weeks, even if the dog looks better earlier.2. First taper (reduce frequency)Once stable for 2β4 weeks with no relapse:Reduce to 5 mg/kg every 48 hours for 4-6 weeks Monitor for recurrence of:rectal bleedingmucusanal gland dischargescooting or discomfortIf relapse occurs ? return to daily dosing.3. Second taperIf still stable after the EOD phase reduce to 5 mg/kg every 72 hoursContinue for 4β8 weeksSome dogs remain stable here long term.4. Long-term maintenance optionsDepending on the dogβs response, maintenance may be every 72 hours vs twice weekly or occasionally discontinuedMany chronic colitis dogs remain stable on low-frequency cyclosporine.5. Practical example protocolA common timeline:Weeks 0β6? 5 mg/kg SIDWeeks 6β12? 5 mg/kg EODWeeks 12β20? 5 mg/kg every 72 hrThen reassess whether ongoing therapy is needed.6. Drugs often continued alongside cyclosporineSulfasalazine during inductionstrict diet trial (e.g. Hill's Prescription Diet z/d)Sulfasalazine is sometimes tapered after cyclosporine is stabilised.7. Monitoring while on cyclosporineMost clinicians check:Baseline then periodic:CBCbiochemistryurinalysisWatch for:GI upset (most common early effect)gingival hyperplasiapapillomasopportunistic infectionsClinical improvement usually appears within 2β4 weeksFull mucosal stabilisation may take 6β8 weeks Vital Signs
Previous claim history (21)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-03-05 | C09992818 | Cruciate Disease - Left Leg |
| 2026-03-05 | C09992818 | INFLAMMATORY BOWEL DISEASE (IBD) |
| 2026-03-05 | C09992818 | Cruciate Disease - Right Leg |
| 2026-02-12 | C09895378 | INFLAMMATORY BOWEL DISEASE (IBD) |
| 2026-01-29 | C09826879 | INFLAMMATORY BOWEL DISEASE (IBD) |
| 2026-01-29 | C09826879 | ANAL SAC DISORDER |
| 2026-01-14 | C09753573 | HEARTWORM CONTROL |
| 2026-01-14 | C09753573 | VACCINATIONS OR HEALTH CHECKS |
| 2026-01-14 | C09753573 | FLEA/TICK/WORM CONTROL |
| 2025-12-30 | C09692664 | ANAL SAC DISORDER |
| 2025-12-27 | C09678386 | PROCTITIS |
| 2025-12-12 | C09624372 | PRESCRIPTION DIETS |
| 2025-12-12 | C09624372 | PROCTITIS |
| 2020-10-08 | C3215235 | DERMATITIS |
| 2020-08-26 | C3121812 | COUGHING - PRESENTING COMPLAINT |
| 2020-07-14 | C3029393 | INSECT BITE/STING |
| 2020-05-15 | C2903765 | HEARTWORM CONTROL |
| 2020-05-15 | C2903765 | FLEA/TICK/WORM CONTROL |
| 2020-05-15 | C2903765 | ANAL SAC DISORDER |
| 2020-03-24 | C2801946 | CHERRY EYE |
| 2020-03-24 | C2801946 | DESEXING |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_antibiotics_-_amoxicillin_and_clavulanic_acid | 309.30 | 2026-03-05 | β |
| 20000 | tstarc_prescription_fee | 25.00 | 2026-03-05 | β |
| 30000 | tstarc_antibiotics_-_metronidazole | 21.80 | 2026-03-05 | β |
UPM+
- DG02377INFLAMMATORY BOWEL DISEASE (IBD)DSTP_inflammatory_bowel_disease_(ibd)
Variant (sleepy_king)
INFLAMMATORY BOWEL DISEASE (IBD)
DSTP_inflammatory_bowel_disease_(ibd)
Conf: 0.720
Threshold: 0.59
Above: β
Correct?